Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag)

被引：0

作者：

Hochmair, M. J. ^{[1
,2
]}

Morabito, A. ^{[3
]}

Hao, D. ^{[4
]}

Yang, C-T. ^{[5
]}

Soo, R. A. ^{[6
]}

Yang, J. C-H. ^{[7
,8
]}

Gucalp, R. ^{[9
]}

Halmos, B. ^{[9
]}

Wang, L. ^{[10
]}

Golembesky, A. ^{[11
]}

Maerten, A. ^{[11
]}

Cufer, T. ^{[12
]}

机构：

[1] Otto Wagner Spital, Dept Resp & Crit Care Med, Vienna, Austria

[2] Otto Wagner Spital, Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria

[3] Ist Nazl Tumori, Thorac Med Oncol, Naples, Italy

[4] Univ Calgary, Cummings Sch Med, Tom Baker Canc Ctr, Calgary, AB, Canada

[5] Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan

[6] Natl Univ Singapore Hosp, Dept Haematol Oncol, Singapore, Singapore

[7] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[8] Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan

[9] Montefiore Albert Einstein Canc Ctr, Dept Oncol, New York, NY USA

[10] Boehringer Ingelheim Taiwan Ltd, Dept Med, Taipei, Taiwan

[11] Boehringer Ingelheim Int GmbH, Dept Med, Ingelheim, Germany

[12] Univ Ljubljana, Univ Clin Golnik, Ljubljana, Slovenia

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA7

引用

页数：2

共 50 条

[1] Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
Hochmair, M. J.
Morabito, A.
Hao, D.
Yang, C.
Soo, R.
Yang, J. C.
Gucalp, R.
Halmos, B.
Golembesky, A.
Maerten, A.
Cufer, T.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1045 - S1045
[2] Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study
Hochmair, M.
Cufer, T.
Morabito, A.
Hao, D.
Yang, C. Ta
Soo, R.
Yang, J.
Gucalp, R.
Halmos, B.
Wang, L.
Golembesky, A.
Maerten, A.
O'Byrne, K.
[J]. LUNG CANCER, 2019, 127 : S59 - S60
[3] Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study
Hochmair, M.
Cufer, T.
Morabito, A.
Hao, D.
Yang, C.
Soo, R.
Yang, J. C.
Gucalp, R. Rasim
Halmos, B.
Wang, L.
Golembesky, A.
Maerten, A.
O'Byrne, K.
[J]. LUNG CANCER, 2019, 127 : S37 - S37
[4] Afatinib followed by osimertinib in patients with EGFR mutation-positive (EGFRm plus ) advanced NSCLC: Updated data from the GioTag real-world study
Hochmair, M. J.
Morabito, A.
Hao, D.
Yang, C-T.
Soo, R.
Yang, J. C-H.
Gucalp, R.
Halmos, B.
Wang, L.
Golembesky, A.
Maerten, A.
Cufer, T.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[5] Sequential afatinib and osimertinib in real-world EGFR mutation positive (EGFRm plus ) NSCLC: Final analysis of Asian patients in the GioTag study
Hochmair, M. J.
Morabito, A.
Hao, D.
Yang, C-T.
Soo, R. A.
Yang, J. C-H.
Gucalp, R.
Halmos, B.
Marten, A.
Cufer, T.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S1399 - S1399
[6] UpSwinG: Real-world study of TKI activity in patients with EGFR mutation-positive (EGFRm plus ) NSCLC with uncommon mutations, and sequencing of afatinib followed by osimertinib
Miura, S.
Maerten, A.
Popat, S.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S1405 - S1406
[7] Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
Halmos, B.
Tan, E.
Soo, R.
Cadranel, J.
Lee, M. K.
Foucher, P.
Hsia, T.
Hochmair, M.
Griesinger, F.
Hida, T.
Kim, E.
Melosky, B.
Maerten, A.
Carcereny, E.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S470 - S471
[8] Osimertinib in EGFR Mutation-Positive Advanced NSCLC
Roca, Elisa
Amoroso, Vito
Berruti, Alfredo
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1261 - 1262
[9] Real-World Management of Patients with EGFR Mutation-Positive NSCLC in the US
Li, Y.
Appius, A.
Pattipaka, T.
Feyereislova, A.
Cassidy, A.
Ganti, A. K.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2216 - S2216
[10] Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)
Halmos, Balazs
Tan, Eng-Huat
Soo, Ross A.
Cadranel, Jacques
Lee, Min Ki
Foucher, Pascal
Hsia, Te-Chun
Hochmair, Maximilian
Griesinger, Frank
Hida, Toyoaki
Kim, Edward
Melosky, Barbara
Maerten, Angela
Carcereny, Enric
[J]. LUNG CANCER, 2019, 127 : 103 - 111

← 1 2 3 4 5 →